Response Oncology Stock Price (OTCMKTS:ROIX)
Latest Stock Market News
Top Stock Gainers
|BioScrip (BIOS)||3.09||0.09 (3%)|
|China Cord Blood Corp (CO)||12.86||0.32 (2.55%)|
|Amedisys (AMED)||50.25||1.08 (2.2%)|
|RadNet (RDNT)||8.35||0.1 (1.21%)|
|Psychemedics (PMD)||20.43||0.23 (1.14%)|
|U.S. Physical Therapy (USPH)||59.25||0.55 (0.94%)|
|Almost Family (AFAM)||48.95||0.45 (0.93%)|
An investor needs to spend 0 to buy ROIX stock, as the closing Response Oncology stock price is 0. Response Oncology market capitalization is 0.12M and it represents the total market value of ROIX stock. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Response Oncology stock analysis.
The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Response Oncology is worth a lot, it will most likely be reflected in an inflated Response Oncology stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 0 ROIX shares were traded yesterday, and Response Oncology stock chart shows that the ROIX stock quote hit a day high of 0 and day low of 0. The board of directors decide what percentage of a company's earnings will be paid out as dividends. One can observe stock price trends and check for volatility by checking Response Oncology stock price history.